Inventor · disambiguated record
Keiji Hasumi
Also filed as: HASUMI KEIJI
8 granted patents·4 pending applications·18 citations·filing 2003–2022
81Inventor score
Top patents by PatentIndex Score
12 records- 0183USRE49351ECytoprotective agentBIOGEN MA INC·Filed 2010·Granted Jan 3, 2023·4 cites·16 claims
- 0273USRE47684ECytoprotective agentTMS CO LTD·Filed 2010·Granted Nov 5, 2019·5 cites·67 claims
- 0373US9078880B2Cytoprotective agentHONDA KAZUO·Filed 2010·Granted Jul 14, 2015·5 cites·4 claims
- 0465US9216987B2Chroman derivativeTMS CO LTD·Filed 2013·Granted Dec 22, 2015·1 cites·10 claims
- 0563US8110596B2Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancerHASUMI KEIJI·Filed 2007·Granted Feb 7, 2012·1 cites·7 claims
- 0662US8193173B2Liver function ameliorantHASUMI KEIJI·Filed 2006·Granted Jun 5, 2012·1 cites·3 claims
- 0761US8883462B2Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancerHASUMI KEIJI·Filed 2012·Granted Nov 11, 2014·1 cites·11 claims
- 0854US2024238252A1Pharmaceutical composition comprising the compound smtp-7JI XING PHARMACEUTICALS HONG KONG LTD·Filed 2022·Application pending·0 cites
- 0953US2024238248A1Pharmaceutical composition for use in treating cerebral infarctionJI XING PHARMACEUTICALS HONG KONG LTD·Filed 2022·Application pending·0 cites
- 1051US7476515B2Affinity trap reactor and single-step process for purifying angiostatin-like fragment from human plasma using the sameTTC CO LTD·Filed 2003·Granted Jan 13, 2009·0 cites·11 claims
- 1142US2011092442A1Anticancer agent containing bl-angiostatinTTC CO LTD·Filed 2004·Application pending·0 cites
- 1232US2009270476A1Pharmaceutical composition for treatment or prevention of nephritis and manufacturing method thereofHASUMI KEIJI·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Keiji Hasumi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →